Y.D. More Investments’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$919K Sell
32,715
-17,444
-35% -$464K 0.04% 115
2025
Q4
$1.25M Buy
50,159
+27,738
+124% +$699K 0.06% 115
2025
Q3
$571K Buy
22,421
+393
+2% +$9.7K 0.03% 147
2025
Q2
$534K Buy
22,028
+1,628
+8% +$38K 0.04% 145
2025
Q1
$517K Sell
20,400
-12,907
-39% -$338K 0.05% 144
2024
Q4
$884K Buy
33,307
+7,602
+30% +$206K 0.08% 117
2024
Q3
$744K Sell
25,705
-32,919
-56% -$960K 0.08% 122
2024
Q2
$1.64M Buy
58,624
+4,544
+8% +$125K 0.17% 80
2024
Q1
$1.5M Sell
54,080
-792,535
-94% -$22M 0.27% 72
2023
Q4
$24.4M Sell
846,615
-16,528
-2% -$500K 4.68% 4
2023
Q3
$28.6M Sell
863,143
-43,379
-5% -$1.53M 5.5% 3
2023
Q2
$33.3M Sell
906,522
-67,612
-7% -$2.63M 7.67% 1
2023
Q1
$39.7M Buy
974,134
+656,059
+206% +$28.3M 8.96% 2
2022
Q4
$16.3M Buy
+318,075
New +$15.2M 3.96% 6

Other funds holding PFE

Y.D. More Investments's PFE Position: Q1 2026 in Review

Y.D. More Investments reduced its Pfizer (PFE) stake by 35% in Q1 2026, selling an estimated $464K and leaving 32,715 shares worth $919K. The position accounts for 0.04% of the portfolio, ranked #115.

Y.D. More Investments first reported a position in PFE in Q4 2022 and has held it in 14 quarters since. The position peaked at $39.7M in Q1 2023. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Y.D. More Investments held 32,715 shares of Pfizer worth $919K as of Q1 2026.
  • Y.D. More Investments sold 17,444 Pfizer shares in Q1 2026, an estimated $464K.
  • Pfizer made up 0.04% of Y.D. More Investments's portfolio in Q1 2026, its #115 holding.
  • Y.D. More Investments first reported a position in Pfizer in Q4 2022 and has held it in 14 quarters since.
  • Y.D. More Investments's Pfizer position peaked at $39.7M in Q1 2023.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Y.D. More Investments's 13F filing for Q1 2026, filed 4 May 2026.